Hospital News and Research

RSS

ERs are swamped with seriously ill patients, although many don’t have covid

Inside the emergency department at Sparrow Hospital in Lansing, Michigan, staff members are struggling to care for patients showing up much sicker than they’ve ever seen.

29 Oct 2021

Study finds early fluvoxamine treatment among COVID-19 patients reduces hospitalization

A team of researchers conducted a randomized, placebo-controlled, adaptive platform trial to evaluate the efficacy of fluvoxamine to prevent COVID-19 progression and hospitalization.

29 Oct 2021

Scientists uncover key genetic networks governing human embryonic stem cell behavior

At the earliest stages of human embryonic development, a small collection of cells known as human embryonic stem cells (hESCs) orchestrates growth and differentiation, eventually giving rise to highly specialized human tissues.

28 Oct 2021

Many students urged to join in COVID-19 screening program to help keep Cambridge safe

An estimated 7,000 students are already taking part each week in the University of Cambridge's Asymptomatic COVID-19 Screening Programme, but the team running the program are encouraging as many students as possible to join in, and help keep Cambridge safe.

28 Oct 2021

Chest discomfort associated with a heart event may be felt beyond the chest

Chest discomfort associated with a heart attack or heart event may often be felt beyond the chest, with many people reporting pain in their shoulders, arms, jaw, neck, back and upper abdomen.

28 Oct 2021

Unique breath test is highly accurate in identifying COVID-19 in critically ill patients

Instead of an invasive nasal swab, researchers at The Ohio State University Wexner Medical Center are exploring the use of a unique breath test for the rapid screening of patients for COVID-19.

28 Oct 2021

Combining clinical and EEG factors can help better predict treatment response in epilepsy patients

Combining electroencephalogram (EEG) data with clinical observations can help doctors to better determine whether generalized epilepsy patients will respond to treatment, according to a study led by Rutgers researchers.

28 Oct 2021

Diet-associated molecules in the gut are linked with aggressive prostate cancer

Cleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, suggesting dietary interventions may help reduce risk. Findings from the study were published in Cancer Epidemiology, Biomarkers & Prevention.

28 Oct 2021

Third dose of Covid-19 vaccine benefits dialysis patients

In some patients, the immune system responds poorly to the second vaccination dose. This changes with the third shot.

28 Oct 2021

Study offers hope for a new therapeutic option for patients with severe asthma

A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health Cohen Family Asthma Institute, found that itepekimab was safe and effective in a phase 2 trial published online today in the New England Journal of Medicine.

28 Oct 2021

Immune cell patterns can help predict if kidney cancer patients will respond to immunotherapy

Researchers at the Francis Crick Institute, The Royal Marsden NHS Foundation Trust and UCL have found immune cell patterns within tumors that can help predict if patients with kidney cancer will respond to immunotherapy.

28 Oct 2021

Malaria: An Interview with the World Health Organization

In this interview, we spoke to Dr. Akpaka Kalu, the World Health Organization's team leader for malaria in Africa, about the groundbreaking malaria vaccine rollout announcement.

28 Oct 2021

Medicare punishes 2,499 hospitals for high readmissions

The federal government's effort to penalize hospitals for excessive patient readmissions is ending its first decade with Medicare cutting payments to nearly half the nation's hospitals.

28 Oct 2021

Democrats’ plans to expand Medicare benefits put pinch on advantage plans’ funding

"Did you think we wouldn't notice?" an older woman says, speaking into the camera. "You thought you could sneak this through?" an older man later adds. Others warn that Washington is "messing with" their Medicare Advantage health coverage and trying to raise their premiums.

28 Oct 2021

Using fluvoxamine to treat COVID-19 patients reduces the need for prolonged hospitalization, trial shows

The results of a new randomized clinical trial, published in The Lancet Global Health, have demonstrated that using fluvoxamine to treat high-risk outpatients with early-diagnosed COVID-19 reduced the need for prolonged observation in an emergency setting or hospitalization, compared to a control group who received a placebo.

28 Oct 2021

Japanese study on SARS-CoV-2 breakthrough infections

Researchers evaluated SARS-CoV-2 incidence in Japan regarding the timing of the vaccination program and surge in COVID-19 cases among the staff of a large referral hospital in Tokyo. This study is posted to the medRxiv* preprint server.

28 Oct 2021

A low-cost repurposed drug can save COVID-19 patients' lives

An inexpensive repurposed drug called fluvoxamine can save the lives of COVID-19 patients and cut hospital admissions by up to 30 per cent, says a study co-led by McMaster University.

27 Oct 2021

New mechanisms for treating impregnable KRAS mutant cancers with statins

Third-generation cancer immunotherapy, a method of removing cancer using the body's immune system, has shown remarkable clinical benefits in recent years, giving hopes to many researchers and patients.

27 Oct 2021

Study: Younger and older patients with metastatic colorectal cancer survive for same amount of time

Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study by Dana-Farber Cancer Institute investigators.

27 Oct 2021

SARS-CoV-2 infection leads to greater risk of neurological complications than vaccines

Researchers from across the UK, led by the University of Oxford, have today reported on the risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.

27 Oct 2021

Hospital News and Research

ERs are swamped with seriously ill patients, although many don’t have covid

Study finds early fluvoxamine treatment among COVID-19 patients reduces hospitalization

Scientists uncover key genetic networks governing human embryonic stem cell behavior

Many students urged to join in COVID-19 screening program to help keep Cambridge safe

Chest discomfort associated with a heart event may be felt beyond the chest

Unique breath test is highly accurate in identifying COVID-19 in critically ill patients

Combining clinical and EEG factors can help better predict treatment response in epilepsy patients

Diet-associated molecules in the gut are linked with aggressive prostate cancer

Third dose of Covid-19 vaccine benefits dialysis patients

Study offers hope for a new therapeutic option for patients with severe asthma

Immune cell patterns can help predict if kidney cancer patients will respond to immunotherapy

Malaria: An Interview with the World Health Organization

Medicare punishes 2,499 hospitals for high readmissions

Democrats’ plans to expand Medicare benefits put pinch on advantage plans’ funding

Using fluvoxamine to treat COVID-19 patients reduces the need for prolonged hospitalization, trial shows

Japanese study on SARS-CoV-2 breakthrough infections

A low-cost repurposed drug can save COVID-19 patients' lives

New mechanisms for treating impregnable KRAS mutant cancers with statins

Study: Younger and older patients with metastatic colorectal cancer survive for same amount of time

SARS-CoV-2 infection leads to greater risk of neurological complications than vaccines

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News